Benzinga | Aug 6, 2020 08:27AM EDT

Albireo Pharma Q2 EPS $(1.38) Beats $(1.69) Estimate, Sales $1.91M Beat $1.28M Estimate

Albireo Pharma (NASDAQ:ALBO) reported quarterly losses of $(1.38) per share which beat the analyst consensus estimate of $(1.69) by 18.34 percent. This is a 2.22 percent decrease over losses of $(1.35) per share from the same period last year. The company reported quarterly sales of $1.91 million which beat the analyst consensus estimate of $1.28 million by 49.38 percent. This is a 52.96 percent increase over sales of $1.25 million the same period last year.